Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23471 | 23750414 | Zhong Yao Cai | [Effects of soothing liver and invigorating spleen recipes on the mRNA and protein expression of TLR4 in hepatic tissues of rats with NASH]. | 2013 | Details |
| A23472 | 23749645 | Cancer Res | Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. | 2013 | Details |
| A23473 | 23747427 | Toxicol Lett | Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation. | 2013 | Details |
| A23474 | 23747246 | Cell Metab | Innate immune receptors: key regulators of metabolic disease progression. | 2013 | Details |
| A23475 | 23746214 | Clin Endocrinol (Oxf) | A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease. | 2013 | Details |
| A23476 | 23745619 | Metab Syndr Relat Disord | Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. | 2013 | Details |
| A23477 | 23745129 | Hepat Mon | Paediatric non-alcoholic Fatty liver disease: impact on patients and mothers' quality of life. | 2013 | Details |
| A23479 | 23744740 | Am J Physiol Gastrointest Liver Physiol | CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. | 2013 | Details |
| A23480 | 23743495 | Redox Rep | The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. | 2013 | Details |
| A23481 | 23742138 | J Agric Food Chem | Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice. | 2013 | Details |
| A23482 | 23740679 | J Pediatr Endocrinol Metab | Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents. | 2013 | Details |
| A23483 | 23740153 | Obes Surg | Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis. | 2013 | Details |
| A23484 | 23739675 | Int J Mol Sci | In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23485 | 23738963 | Liver Int | MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population. | 2013 | Details |
| A23486 | 23737773 | Int J Endocrinol | Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD. | 2013 | Details |
| A23487 | 23737763 | Gastroenterol Res Pract | Time course of the development of nonalcoholic Fatty liver disease in the Otsuka long-evans Tokushima Fatty rat. | 2013 | Details |
| A23488 | 23737314 | Acta Med Iran | Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. | 2013 | Details |
| A23489 | 23735917 | Am J Gastroenterol | Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? | 2013 | Details |
| A23490 | 23734760 | Metab Syndr Relat Disord | Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. | 2013 | Details |
| A23491 | 23733885 | J Lipid Res | Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice. | 2013 | Details |
| A23492 | 23731881 | Best Pract Res Clin Endocrinol Metab | Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae. | 2013 | Details |
| A23493 | 23731053 | J Gastroenterol Hepatol | Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China. | 2013 | Details |
| A23494 | 23730487 | Korean J Fam Med | Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. | 2013 | Details |
| A23495 | 23727306 | J Hepatol | Dendritic cells in liver injury and fibrosis: shortcomings and promises. | 2013 | Details |
| A23496 | 23727264 | Gastroenterology | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23497 | 23727030 | Clin Chim Acta | Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. | 2013 | Details |
| A23498 | 23721951 | Exp Gerontol | Prevalence and associated metabolic factors of fatty liver disease in the elderly. | 2013 | Details |
| A23499 | 23721476 | Hepatol Res | Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23500 | 23721173 | J Transl Med | Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). | 2013 | Details |
| A23502 | 26201794 | Hepatol Int | Fatty liver score and 15-year incidence of type 2 diabetes. | 2013 | Details |
| A23503 | 26201793 | Hepatol Int | Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative. | 2013 | Details |
| A23504 | 26201791 | Hepatol Int | Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components. | 2012 | Details |
| A23505 | 26201789 | Hepatol Int | Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. | 2012 | Details |
| A23506 | 26201788 | Hepatol Int | Maturation defective myeloid dendritic cells in nonalcoholic fatty liver disease patients release inflammatory cytokines in response to endotoxin. | 2012 | Details |
| A23507 | 26201786 | Hepatol Int | Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. | 2012 | Details |
| A23508 | 26201775 | Hepatol Int | Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? | 2012 | Details |
| A23509 | 26201774 | Hepatol Int | Nonalcoholic fatty liver disease following liver transplantation. | 2013 | Details |
| A23510 | 25755488 | J Clin Exp Hepatol | Gut-liver axis: role of inflammasomes. | 2013 | Details |
| A23511 | 25755484 | J Clin Exp Hepatol | The future liver of the Asia pacific: fatter and firmer from more fructose and fortune? | 2012 | Details |
| A23512 | 23720231 | Dis Model Mech | The expanding role of fish models in understanding non-alcoholic fatty liver disease. | 2013 | Details |
| A23514 | 23718963 | J Mol Endocrinol | Molecular pathways involved in the improvement of non-alcoholic fatty liver disease. | 2013 | Details |
| A23515 | 23718573 | Aliment Pharmacol Ther | Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. | 2013 | Details |
| A23516 | 23717739 | World J Hepatol | Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. | 2013 | Details |
| A23517 | 23717737 | World J Hepatol | Transient elastography: Kill two birds with one stone? | 2013 | Details |
| A23518 | 23716995 | World J Gastroenterol | Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. | 2013 | Details |
| A23519 | 23715726 | Am J Physiol Endocrinol Metab | Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet. | 2013 | Details |
| A23520 | 23714479 | Am Soc Clin Oncol Educ Book | How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC? | 2013 | Details |
| A23521 | 23714158 | J Hepatol | The metabolomic window into hepatobiliary disease. | 2013 | Details |
| A23522 | 23711137 | Am J Chin Med | Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. | 2013 | Details |
| A23523 | 23710314 | Gut Liver | Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score. | 2013 | Details |
| A23524 | 23707663 | Biochim Biophys Acta | Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells. | 2013 | Details |
| A23525 | 23707549 | Pathol Res Pract | Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. | 2013 | Details |
| A23528 | 23705529 | Adolesc Med State Art Rev | Update in adolescent gastroenterology. | 2013 | Details |
| A23529 | 23703888 | Am J Epidemiol | Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. | 2013 | Details |
| A23530 | 23703776 | Hepatology | Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. | 2013 | Details |
| A23531 | 23703665 | Hepatology | Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. | 2013 | Details |
| A23532 | 23703580 | Hepatology | Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2013 | Details |
| A23533 | 23703028 | Mol Cell Biochem | Endoplasmic reticulum stress leads to lipid accumulation through upregulation of SREBP-1c in normal hepatic and hepatoma cells. | 2013 | Details |
| A23534 | 23702499 | Med Ultrason | Can transient elastography be a reliable method for assessing liver fibrosis in non alcoholic steatohepatitis (NASH)? | 2013 | Details |
| A23535 | 23702383 | Metabolism | Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. | 2013 | Details |
| A23536 | 23702094 | BMC Pediatr | Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. | 2013 | Details |
| A23537 | 23701491 | J Gastroenterol Hepatol | Hepatic steatosis and severity-related factors in obese children. | 2013 | Details |
| A23538 | 23701387 | Hepatol Res | Osteopontin: Versatile modulator of liver diseases. | 2013 | Details |
| A23539 | 23700488 | PLoS One | Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH. | 2013 | Details |
| A23540 | 23698776 | Int J Mol Sci | Obesity-associated oxidative stress: strategies finalized to improve redox state. | 2013 | Details |
| A23541 | 23697659 | Antioxid Redox Signal | A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia. | 2013 | Details |
| A23542 | 23696823 | PLoS One | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. | 2013 | Details |
| A23543 | 23696515 | Hepatology | Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. | 2013 | Details |
| A23544 | 23695216 | Am J Physiol Endocrinol Metab | Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. | 2013 | Details |
| A23545 | 23694813 | Clin Chim Acta | Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia. | 2013 | Details |
| A23546 | 23692373 | Diabet Med | Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. | 2013 | Details |
| A23547 | 23692125 | Free Radic Res | A high-fat and cholesterol diet causes fatty liver in guinea pigs. The role of iron and oxidative damage. | 2013 | Details |
| A23548 | 23691641 | Southeast Asian J Trop Med Public Health | Prevalence of ultrasound diagnosed nonalcoholic fatty liver disease among rural indigenous community of Sarawak and its association with biochemical and anthropometric measures. | 2013 | Details |
| A23549 | 23691267 | Oxid Med Cell Longev | Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease. | 2013 | Details |
| A23550 | 23690772 | Int J Endocrinol | Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. | 2013 | Details |
| A23551 | 23690766 | Int J Endocrinol | Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. | 2013 | Details |
| A23552 | 23688357 | Cardiovasc Diabetol | Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. | 2013 | Details |
| A23553 | 23688034 | BMC Med Genet | Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver. | 2013 | Details |
| A23554 | 23686698 | Hepatology | Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. | 2013 | Details |
| A23555 | 23686653 | Obes Surg | Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients. | 2013 | Details |
| A23556 | 23684211 | Rev Assoc Med Bras (1992) | Association between nonalcoholic fatty liver disease and coronary artery disease. | 2013 | Details |
| A23557 | 23682724 | Liver Int | Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet. | 2013 | Details |
| A23558 | 23678860 | J Dig Dis | Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico. | 2013 | Details |
| A23559 | 23676586 | Intern Med | Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. | 2013 | Details |
| A23560 | 23674845 | World J Gastroenterol | Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. | 2013 | Details |
| A23562 | 23672077 | Rinsho Byori | [Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis]. | 2013 | Details |
| A23563 | 23671723 | World J Hepatol | CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. | 2013 | Details |
| A23564 | 23671720 | World J Hepatol | Melatonin attenuates high fat diet-induced fatty liver disease in rats. | 2013 | Details |
| A23565 | 23671610 | PLoS One | The association between nonalcoholic fatty pancreas disease and diabetes. | 2013 | Details |
| A23566 | 23669283 | J Hepatol | NKT-cell subsets: promoters and protectors in inflammatory liver disease. | 2013 | Details |
| A23567 | 23668723 | Proc Nutr Soc | Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. | 2013 | Details |
| A23568 | 23666886 | Obesity (Silver Spring) | Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease. | 2013 | Details |
| A23569 | 23666091 | Nutrients | Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. | 2013 | Details |
| A23570 | 23665288 | J Hepatol | A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. | 2013 | Details |
| A23571 | 23665283 | J Hepatol | Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. | 2013 | Details |
| A23572 | 23665282 | J Hepatol | Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. | 2013 | Details |
| A23573 | 23663887 | Zhonghua Gan Zang Bing Za Zhi | [Therapeutic efficacy and mechanisms of quercetin in a rat model of nonalcoholic fatty liver disease]. | 2013 | Details |
| A23574 | 23663767 | Zhonghua Gan Zang Bing Za Zhi | [Effects of quercetin on serum levels of resistin and IL-18 and on insulin resistance in nonalcoholic fatty liver disease rats]. | 2013 | Details |
| A23575 | 23663766 | Zhonghua Gan Zang Bing Za Zhi | [Risk factors analysis of nonalcoholic fatty liver disease in Chinese men]. | 2013 | Details |
| A23576 | 23663765 | Zhonghua Gan Zang Bing Za Zhi | [Significance of high sensitivity C-reactive protein level for predicting risk of nonalcoholic fatty liver in type 2 diabetes mellitus patients]. | 2013 | Details |